首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠心病痰瘀证客观指标的临床研究
引用本文:靳宏光,齐锋,王义强,赵明,陈颖,李哲山.冠心病痰瘀证客观指标的临床研究[J].世界科学技术-中医药现代化,2013,15(5):1032-1036.
作者姓名:靳宏光  齐锋  王义强  赵明  陈颖  李哲山
作者单位:长春中医药大学附属医院 长春 130021;长春中医药大学附属医院 长春 130021;长春中医药大学附属医院 长春 130021;长春中医药大学附属医院 长春 130021;长春中医药大学附属医院 长春 130021;长春市中医院 长春 130022
基金项目:吉林省中医药管理局资助项目(2011-044):基于痰瘀伏邪病因的中医药干预冠心病稳定性心绞痛(缓解期)优化方案研究,负责人:陈颖。
摘    要:目的:探讨冠心病痰瘀证与多个客观指标的相关性,为冠心病痰瘀证的临床研究提供依据。方法:将120 例冠心病患者分为痰瘀证组(76 例)和非痰瘀证组(44 例),另选择体检健康者20 例设为正常对照组,从血脂、糖代谢、炎症因子等方面进行比较和统计学分析。结果:痰瘀证组在总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、血胰岛素(FINS)、超敏C 反应蛋白(hs-CRP)、基质金属蛋白酶-9(MMP-9)水平方面均明显高于正常对照组及非痰瘀证组(P<0.05 或P<0.01)。结论:TC、TG、LDL-C、FINS、hs-CRP、MMP-9 水平可为冠心病痰瘀辨证分型提供客观依据。

关 键 词:冠心病  痰瘀证  临床研究  辨证分型
收稿时间:2013/4/19 0:00:00
修稿时间:2013/6/19 0:00:00

Clinical Study on Objective Indexes of Phlegm-stasis Syndrome of Coronary Heart Disease
Jin Hongguang,Qi Feng,Wang Yiqiang,Zhao Ming,Chen Ying and Li Zheshan.Clinical Study on Objective Indexes of Phlegm-stasis Syndrome of Coronary Heart Disease[J].World Science and Technology-Modernization of Traditional Chinese Medicine,2013,15(5):1032-1036.
Authors:Jin Hongguang  Qi Feng  Wang Yiqiang  Zhao Ming  Chen Ying and Li Zheshan
Institution:The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, China;Changchun Hospital of Traditional Chinese Medicine, Changchun 130022, China
Abstract:This study was aimed to explore the correlation between the phlegm -stasis syndrome of coronary heart disease (CHD) and multiple objective indexes in order to provide the basis for clinical study of phlegmstasis syndrome of CHD. A total of 120 patients were divided into the phlegm -stasis syndrome group (76cases) and the non -phlegm -stasis syndrome group (44 cases). And 20 cases of healthy volunteers were selected as the normal control group. Comparison and statistical analysis were made from aspects of blood lipids, glucose metabolism, inflammation factor and etc. The results showed that the levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), fasting insulin (FINS), hypersensitive Creactive protein (hs-CRP), matrix metalloproteinase-9 (MMP-9) in the phlegm-stasis syndrome group were significantly higher than those in the normal control group and the non-phlegm-stasis syndrome group (P <0.05, or P < 0.01). It was concluded that the levels of TC, TG, LDL-C, FINS, hs-CRP and MMP-9 can provide objective basis for the phlegm-stasis syndrome of CHD.
Keywords:Coronary heart disease  phlegm-stasis syndrome  clinical study  syndrome differentiation
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号